Eleni Makrodouli

Eleni Makrodouli

Auto-generated profile, based on publicly available information

Eleni Makrodouli

Laboratory of Signal Mediated Gene Expression, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Vas, Constantinou Ave. 48, 11635, Athens, Greece

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2011 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
EMEleni Makrodouli
Eleni Makrodouli
EOEftychia Oikonomou
Eftychia Oikonomou
MKMichal Koc
Michal Koc
LALadislav Andera
Ladislav Andera
TSTakehiko Sasazuki
Takehiko Sasazuki
APAlexander Pintzas
Alexander Pintzas
Background: Colorectal cancer is a common disease that involves genetic alterations, such as inactivation of tumour suppressor genes and activation of oncogenes. Among them are RAS and BRAF mutations, which rarely coexist in the same tumour. Individual members of the Rho (Ras homology) GTPases contribute with distinct roles in tumour cell morphology, invasion and metastasis. The aim of this study is to dissect cell migration and invasion pathways that are utilised by BRAFV600Eas compared to KRASG12Vand HRASG12Voncoproteins. In particular, the role of RhoA (Ras homolog gene family, member A), Rac1 (Ras-related C3 botulinum toxin substrate 1) and Cdc42 (cell division cycle 42) in cancer progression induced by each of the three oncogenes is described.Methods: Colon adenocarcinoma cells with endogenous as well as ectopically expressed or silenced oncogenic mutations of BRAFV600E, KRASG12Vand HRASG12Vwere employed. Signalling pathways and Rho GTPases were inhibited with specific kinase inhibitors and siRNAs. Cell motility and invasion properties were correlated with cytoskeletal properties and Rho GTPase activities.Results: Evidence presented here indicate that BRAFV600Esignificantly induces cell migration and invasion propertiesin vitroin colon cancer cells, at least in part through activation of RhoA GTPase. The relationship established between BRAFV600Eand RhoA activation is mediated by the MEK-ERK pathway. In parallel, KRASG12Venhances the ability of colon adenocarcinoma cells Caco-2 to migrate and invade through filopodia formation and PI3K-dependent Cdc42 activation. Ultimately increased cell migration and invasion, mediated by Rac1, along with the mesenchymal morphology obtained through the Epithelial-Mesenchymal Transition (EMT) were the main characteristics rendered by HRASG12Vin Caco-2 cells. Moreover, BRAF and KRAS oncogenes are shown to cooperate with the TGFβ-1 pathway to provide cells with additional transforming properties.Conclusion: This study discriminates oncogene-specific cell migration and invasion pathways mediated by Rho GTPases in colon cancer cells and reveals potential new oncogene-specific characteristics for targeted therapeutics.